Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|October 15, 2015
Hypoxia pretreatment of bone marrow-derived mesenchymal stem cells seeded in a collagen-chitosan sponge scaffold promotes skin wound healing in diabetic rats with hindlimb ischemiaChuan Tong, Haojie Hao, Lei Xia, et al.
Frontiers in Oncology|November 16, 2020
Case Report: Low-Dose Decitabine Plus Anti-PD-1 Inhibitor Camrelizumab for Previously Treated Advanced Metastatic Non-Small Cell Lung CancerXin Yan, Yongtian Zhao, Yang Liu, et al.
Journal of Hematology & Oncology|June 12, 2019
Haploidentical CD19/CD22 bispecific CAR-T cells induced MRD-negative remission in a patient with relapsed and refractory adult B-ALL after haploidentical hematopoietic stem cell transplantationHejin Jia, Zhenguang Wang, Yao Wang, et al.
Biochemical and Biophysical Research Communications|June 18, 2013
Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes ratsHaojie Hao, Jiejie Liu, Jing Shen, et al.
Journal of Hematology & Oncology|April 5, 2020
Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Zhiqiang Wu, Hejin Jia, et al.
Blood|June 20, 2020
Optimized tandem CD19/CD20 CAR-engineered T cells in refractory/relapsed B-cell lymphomaChuan Tong, Yajing Zhang, Yang Liu, et al.
Journal of Hematology & Oncology|May 20, 2020
Correction to: Bispecific CAR-T cells targeting both CD19 and CD22 for therapy of adults with relapsed or refractory B cell acute lymphoblastic leukemiaHanren Dai, Zhiqiang Wu, Hejin Jia, et al.
Nature Communications|January 19, 2021
Low-dose decitabine priming endows CAR T cells with enhanced and persistent antitumour potential via epigenetic reprogrammingYao Wang, Chuan Tong, Hanren Dai, et al.
Pageof 3